# Adipose tissue and adipose-derived stromal cells can reduce skin contraction in an in vitro tissue engineered full thickness skin model

## TL;DR

Adipose tissue and its cells can reduce skin contraction in a lab-grown skin model, suggesting potential for treating skin contractures in patients.

## Contribution

The study demonstrates that adipose tissue and high-dose adipose-derived stromal cells inhibit skin contraction in vitro.

## Key findings

- Untreated engineered skin contracted to 60% of its original area over 14 days.
- Adipose tissue reduced contraction by 50%, and high doses of ADSC had a similar effect.
- Lower doses of ADSC did not inhibit contraction effectively.

## Abstract

Skin contracts during wound healing to facilitate wound closure. In some patients, skin contraction can lead to the formation of skin contractures that limit movement, impair function, and significantly impact well-being. Current treatment options for skin contractures are burdensome for patients, and there is a high risk of recurrence. Autologous fat grafting can improve the structure and function of scarred skin; however, relatively little is known about the effect of fat on skin contraction. In this study, an in vitro tissue-engineered model of human skin was used to test the effects of adipose tissue and adipose-derived stromal cells on skin contraction. Untreated tissue-engineered skin contracted to approximately 60% of the original area over 14 days in culture. The addition of adipose tissue reduced this contraction by 50%. Adipose tissue, which was emulsified or concentrated and high doses of adipose-derived stromal cells (ADSC) were able to inhibit contraction to a similar degree; however, lower doses of ADSC did not show the same effect. In conclusion, the subcutaneous application of adipose tissue has the potential to inhibit skin contraction. This study provides in vitro evidence to support the use of autologous fat grafting to prevent skin contraction in patients most at risk.